Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Kurt Azarbarzin
AddedMar 31, 2024
UpdatedMay 31, 2026
Kurt Azarbarzin

Kurt Azarbarzin

Board Member, Tela Bio

CrunchbaseLinkedIn

Kurt Azarbarzin's Career

Tela Bio
Tela Bio

Malvern, PA, US

Board Member· Board
ColubrisMX
ColubrisMX

Houston, TX, US

CEO· C-Suite · Management
EndoQuest Robotics
EndoQuest Robotics

Houston, TX, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Kurt Azarbarzin's Career

Tela Bio
Tela Bio
Public$230.4M1232012Malvern, PA, US
Board Member· Board

Leadership at Tela Bio

Doug EvansDoug EvansBoard Member
Kevin RakinKevin RakinBoard Member
Lisa N ColleranLisa N ColleranBoard Member
Maarten PersenaireMaarten PersenaireCo-Founder
John NosenzoJohn NosenzoBoard Member
Antony KoblishAntony KoblishBoard Member

Similar to Tela Bio

BioTissueBioTissueMiami, FL, USTissue, Wound Healingest. 1997BioTissueMiami, FL, US · est. 1997

Biotissue Holdings Inc., a US-based company, specializes in regenerative wound healing using human birth tissues.

Public · $110M365
TissueFormTissueFormBoulder, CO, USBiomaterialsest. 2019TissueFormBoulder, CO, US · est. 2019

TissueForm: Advancing biomaterials for regenerative medicine and plastic surgery solutions.

Angel · $250k2
Telesis BioTelesis BioSan Diego, CA, USLab Equipment, Reagentsest. 2013Telesis BioSan Diego, CA, US · est. 2013

Telesis Bio Inc.: Global biotech firm specializing in synthetic biology instruments and lab products.

Public · $74.2M128
inSoma BioinSoma BioDurham, NC, USMedical Devicesest. 2018inSoma BioDurham, NC, US · est. 2018

InSoma Bio: Innovating natural solutions for reconstructive plastic surgery using patient's own tissue.

Seed · $3.1M5
ColubrisMX
ColubrisMX
Series B$86.7M1752017Houston, TX, US
CEO· C-Suite · Management

Leadership at ColubrisMX

Daniel H. KimDaniel H. KimFounder

Similar to ColubrisMX

EndoQuest RoboticsEndoQuest RoboticsHouston, TX, USRobotic Surgeryest. 2017EndoQuest RoboticsHouston, TX, US · est. 2017

EndoQuest Robotics: Innovating minimally invasive microsurgical robotic devices.

Series C · $42M75
Microbot MedicalMicrobot MedicalHingham, MA, USMedical Devicesest. 1988Microbot MedicalHingham, MA, US · est. 1988

Microbot Medical Inc., a Massachusetts-based company, specializes in developing and commercializing micro-robotics assisted medical technologies.

Public21
Surgical AutomationsSurgical AutomationsDallas, TX, USSurgical Robotsest. 2023Surgical AutomationsDallas, TX, US · est. 2023

Surgical Automations: Developing AI-powered surgical robots for precise endoscopic procedures.

Pre-Seed · $835k3
XCathXCathHouston, TX, USMedical Devicesest. 2017XCathHouston, TX, US · est. 2017

XCath develops steerable robotic microcatheters for remote treatment of endovascular conditions.

Series A · $5.3M6
EndoQuest Robotics
EndoQuest Robotics
Series C$42M752017Houston, TX, US
CEO· C-Suite · Management

Similar to EndoQuest Robotics

Virtuoso SurgicalVirtuoso SurgicalNashville, TN, USSurgical Roboticsest. 2016Virtuoso SurgicalNashville, TN, US · est. 2016

Virtuoso Surgical develops advanced endoscopic robotic tools for minimally invasive surgeries.

Seed · $2M12
Surgical AutomationsSurgical AutomationsDallas, TX, USSurgical Robotsest. 2023Surgical AutomationsDallas, TX, US · est. 2023

Surgical Automations: Developing AI-powered surgical robots for precise endoscopic procedures.

Pre-Seed · $835k3
Virtual IncisionVirtual IncisionLincoln, NE, USSurgical Devicesest. 2006Virtual IncisionLincoln, NE, US · est. 2006

Virtual Incision: Innovating miniaturized robotic devices for efficient colon resection.

Series C · $146M66
Agile EndoSurgeryAgile EndoSurgeryChapel Hill, NC, USSurgical Instrumentsest. 2010Agile EndoSurgeryChapel Hill, NC, US · est. 2010

Agile EndoSurgery, based in Durham, US, develops advanced surgical tools to enhance minimally invasive surgery.

Seed · $258.7k5

Kurt Azarbarzin's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Kurt Azarbarzin

Chris ZiomekChris ZiomekBoard Member · EnthenticaBalaji ViswanathanBalaji ViswanathanCEO · ZingfinJeffrey A BeckJeffrey A BeckBoard Member · inTESTElad InbarElad InbarCo-Founder & CEO · Robot App StoreReza ZadnoReza ZadnoBoard Member · PROCEPT BioRobotics